Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Jalpa Shah et al.|Cancer Research|2016Cited by 115
Abstract 207: Dual targeting of DLL4 and VEGF signaling by a novel bispecific antibody inhibits tumor growth and reduces cancer stem cell frequencyWan-Ching Yen, Timothy Hoey, Fumiko Axelrod et al.|Cancer Research|2014Cited by 1
Abstract 1764: Inhibition of R-spondin (RSPO) signaling reduces the growth of multiple human tumorsAustin Gurney, Timothy Hoey, Fumiko Axelrod et al.|Cancer Research|2014Cited by 0
Abstract 4330: <i>In vivo</i> evaluation of anti-tumor activity by an anti-VEGF and anti-DLL4 bispecific antibody in a humanized model of skin graft.Lucia Beviglia, Timothy Hoey, Pete Yeung et al.|Cancer Research|2013Cited by 0